COMPARATIVE STUDY OF PROBIOTICS AND PLACEBO IN THE PREVENTION OF NECROTIZING ENTEROCOLITIS IN PREMATURE INFANTS
Main Article Content
Keywords
necrotizing enterocolitis, probiotics, premature infants, observational study, neonatal care, Lactobacillus, Bifidobacterium, mortality, sepsis, health outcomes
Abstract
Background: Necrotizing enterocolitis (NEC) severely impacts premature infants, leading to high morbidity and mortality rates. Despite medical advances, effective prevention remains elusive. Probiotics, which stabilize gut flora and boost immune responses, could be a viable preventive measure.
Objective: This study evaluates the effectiveness of probiotics in reducing NEC incidence in a clinical setting, aiming to establish them as a standard preventive treatment.
Methods: This observational prospective cohort study was conducted at Abbasi Shaheed Hospital, Karachi Pakistan in the duration from July, 2023 to December, 2023. it involves 102 preterm infants under 34 weeks gestational age. The study divided infants into two groups: those receiving daily probiotics (Lactobacillus and Bifidobacterium) and a control group without supplements. Primary outcomes included NEC incidence, mortality, and sepsis rates. Analysis was performed using SPSS, with Kaplan-Meier and Cox proportional hazards models.
Results: Probiotics significantly reduced NEC incidence to 4% versus 16% in controls. Notable declines in mortality and sepsis were also observed. Probiotic recipients benefitted from better growth rates and shorter hospital stays.
Conclusion: Probiotics markedly decrease NEC risks among preterm infants, advocating their integration into neonatal care. This study supports the broader implementation of probiotics as a straightforward, cost-effective strategy to avert a critical condition, reshaping care for at-risk neonates.
References
2. Hunter CJ, Upperman JS, Ford HR, Camerini V. Understanding the susceptibility of the premature infant to necrotizing enterocolitis (NEC). Pediatr Res. 2008;63(2):117-123.
3. Lin HC, Hsu CH, Chen HL, Chung MY, Hsu JF, Lien RI, et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics. 2005;115(1):1-4.
4. Alfaleh K, Anabrees J, Bassler D, Al-Kharfi T. Probiotics for prevention of necrotizing enterocolitis in preterm neonates. Cochrane Database Syst Rev. 2011;(3)
5. Deshpande G, Rao S, Patole S, Bulsara M. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics. 2010;125(5):921-930.
6. Underwood MA. Probiotics and the prevention of necrotizing enterocolitis. J Pediatr Surg. 2019;54(3):405-412.
9. Bin-Nun A, Bromiker R, Wilschanski M, Kaplan M, Rudensky B, Caplan M, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr. 2005;147(2):192-196.
10. Mihatsch WA, Braegger CP, Decsi T, Kolacek S, Lanzinger H, Mayer B, et al. Critical systematic review of the level of evidence for routine use of probiotics in preterm infants. J Pediatr Gastroenterol Nutr. 2012;54(5):621-629.
11. Sari FN, Dizdar EA, Oguz S, Erdeve O, Uras N, Dilmen U. Oral probiotics: An intervention to reduce necrotizing enterocolitis rates in very low birth weight infants. Int J Pediatr. 2010.
12. Totsu S, Yamasaki C, Terahara M, Uchiyama A, Kusuda S. Beneficial effects of probiotics on the maturation of the intestinal microbiome in preterm infants. Neonatology. 2016;110(3):221-226.
13. Samanta M, Sarkar M, Ghosh P, Ghosh J, Sinha M, Chatterjee S. Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns. J Trop Pediatr. 2009;55(2):128-131.